Kerman University of Medical Sciences International Journal of Health Policy and Management 2322-5939 8 12 2019 12 01 Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA; Comment on “Ethics in HTA: Examining the ‘Need for Expansion’” 732 733 3664 10.15171/ijhpm.2019.73 EN Anthony J. Culyer Department of Economics and Related Studies and Centre for Health Economics, University of York, York, UK Journal Article 2019 08 16 <span class="fontstyle0">Abrishami, Oortwijn, and Hofman (AOH) attribute to me a position I do not hold and an argument I did not make. The purpose of this note is make clear what my position actually is and to clarify the main differences between health technology assessment (HTA) and cost-effectiveness analysis (CEA).</span> HTA Cost-Effectiveness Analysis Scope Social Value Judgments https://www.ijhpm.com/article_3664_35e593455ea89bb17587ad76966f77a2.pdf